GlaxoSmithKline PLC

Healthcare · Drug Manufacturers - General

50.50$ +0.3% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Income Statement

GlaxoSmithKline PLC (GSK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 8,409 million GBP. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of GBP.

Tick rows to compare them in a chart (up to 4)

Income Statement GSK
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	7,542	7,586	7,384	7,320	7,843	7,639	7,222	7,310	8,092	8,197	7,661	7,809	9,385	8,899	9,090	7,624	8,646	8,739	7,418	5,838	6,627	9,527	7,190	6,929	7,829	7,376	6,951	7,178	8,147	8,052	7,363	7,884	8,012	8,117	7,516	7,986	8,547	8,618	7,629	8,409	33,203
Cost of Revenue	2,525	2,508	2,513	2,619	2,652	2,558	2,391	2,310	2,636	2,904	2,733	2,637	3,245	3,248	3,199	2,449	2,885	3,171	2,480	1,708	2,016	3,680	2,717	2,176	2,423	2,238	1,943	1,932	2,272	2,418	1,970	2,122	2,397	2,559	1,937	2,165	2,258	2,657	1,875	2,266	9,056
Gross Profit	5,017	5,078	4,871	4,701	5,191	5,081	4,831	5,000	5,456	5,293	4,928	5,172	6,140	5,651	5,891	5,175	5,761	5,568	4,938	4,130	4,611	5,847	4,473	4,753	5,406	5,138	5,008	5,246	5,875	5,634	5,393	5,762	5,615	5,558	5,579	5,821	6,289	5,961	5,754	6,143	24,147
Research & Development	922	1,003	960	1,260	1,047	1,209	904	925	988	1,076	1,006	1,113	1,206	1,243	1,187	1,301	1,140	1,470	1,118	1,167	1,416	1,448	1,103	1,242	1,346	1,797	1,260	1,341	1,575	2,047	1,434	1,477	1,459	2,031	1,462	2,024	1,689	2,350	1,692	3,466	9,197
Selling, General & Administrative	2,292	2,711	2,452	2,379	2,308	2,533	2,311	2,457	2,527	2,620	2,477	2,590	2,892	3,443	2,916	2,709	2,669	3,162	2,427	1,689	1,679	3,260	1,812	2,066	2,056	2,438	2,143	2,268	2,296	2,678	2,087	2,465	3,800	2,663	2,070	2,140	2,239	2,639	2,119	2,202	9,199
Total Operating Expenses	3,586	4,483	3,153	4,721	3,314	4,569	3,591	4,221	3,546	3,739	3,500	3,688	3,993	3,749	3,877	2,325	3,903	4,507	3,245	2,855	3,231	4,952	2,180	3,672	4,215	3,270	2,926	3,105	3,926	5,061	3,903	4,116	5,426	4,862	3,363	3,798	3,696	4,455	3,461	5,662	17,274
Operating Income	1,431	595	1,718	-20	1,877	512	1,240	779	1,910	1,554	1,428	1,484	2,147	1,902	2,014	2,850	1,858	1,061	1,693	1,275	1,380	895	2,293	1,081	1,191	1,868	2,082	2,141	1,949	573	1,490	1,646	189	696	2,216	2,023	2,593	1,506	2,293	481	6,873
Interest Expense	179	194	194	192	194	154	162	194	233	212	224	237	245	206	229	229	198	232	201	192	195	188	205	204	200	258	203	185	182	275	166	174	156	144	162	184	167	174	167	182	690
Pre-Tax Income	1,274	423	1,550	-178	1,711	442	1,107	614	1,705	1,374	1,295	1,264	1,951	1,711	1,835	2,641	1,671	821	1,518	1,070	1,192	706	2,094	896	1,012	1,626	1,907	1,987	1,791	379	1,355	1,495	64	563	2,108	1,887	2,456	950	2,144	354	5,904
Income Tax Expense	389	106	327	-92	316	805	348	139	193	74	310	214	235	194	156	201	241	-18	258	-201	246	-224	323	150	233	1.0	276	242	257	-19	274	191	-1.0	62	336	241	312	223	305	-199	641
Net Income	808	257	1,046	-180	1,212	-546	549	441	1,418	1,215	830	964	1,552	1,299	1,565	2,263	1,244	677	1,073	1,395	1,368	749	1,802	838	10,821	1,461	1,490	1,624	1,464	350	1,046	1,173	-58	414	1,624	1,443	2,013	636	1,737	435	4,821
EBITDA	1,644	1,221	2,070	1,101	2,589	424	1,747	1,003	2,434	2,243	2,702	2,277	2,709	2,331	2,258	3,064	2,510	3,239	2,080	1,804	2,296	1,256	2,717	2,017	2,168	2,285	2,750	2,624	2,552	1,157	2,070	2,308	1,171	1,119	3,093	3,230	3,361	1,907	2,774	2,826	10,868

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings